• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码p53蛋白的基因中的沉默突变优先位于保守氨基酸位置和剪接增强子中。

Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.

作者信息

Lamolle Guillermo, Marin Mónica, Alvarez-Valin Fernando

机构信息

Sección Biomatemática, Facultad de Ciencias, Universidad de la República, Iguá 4225, Montevideo, Uruguay.

出版信息

Mutat Res. 2006 Aug 30;600(1-2):102-12. doi: 10.1016/j.mrfmmm.2006.03.004. Epub 2006 May 2.

DOI:10.1016/j.mrfmmm.2006.03.004
PMID:16650445
Abstract

The last release of p53 somatic mutation database contains more than 20,000 of mutation among which 951 are silent (synonymous). This striking amount of silent mutations is much more than what would be expected if synonymous mutations were effectively neutral. The prevalent explanation to reconcile this vast amount of silent mutations with the neutral expectation is that they are just the subproduct of the hypermutability process that affect cancer cells. Some evidences have been presented in this direction, and the explanation has been taken as granted. Assuming that silent mutations are effectively neutral has major implication in the investigation of mutational processes that affect the gene encoding the p53 protein, since on the basis of this assumption they are considered the Null hypothesis, for instance for measuring and comparing among tissues the endogenous mutability. From this it follows that determining whether silent mutations in the p53 gene, and in all disease genes in general, are or not basically mutational noise, is of paramount importance. In this paper we readdress this topic by testing whether there is a relationship between the spatial distribution of silent mutations inside the p53 gene and functional significant features of the gene. For this purpose we divided the population of silent mutations in three groups: those that are found accompanied by other mutations (doublets and multiplest), those that were isolated as singlets, but the same mutation was also isolated as being part of a doublet (or multiplet) in another individual. And the last group is composed by those that were always found as singlets and never as being part of a doublet or a multiplet. This last group was expected to be enriched in functionally significant silent mutations. We found that all silent mutations, but particularly those of the last group, are preferentially located in conserved amino acid positions (i.e. functionally important amino acids) and also tend to be located inside suspected splicing enhancers. Noteworthy, this association remains even after eliminating the possible contribution of mutation hotspots. Besides, we present additional evidence in the direction that these putative splicing enhancers are real functional enhancers.

摘要

p53体细胞突变数据库的最新版本包含20000多个突变,其中951个是沉默(同义)突变。这一惊人数量的沉默突变远远超过了如果同义突变实际上是中性的情况下所预期的数量。将如此大量的沉默突变与中性预期相协调的普遍解释是,它们只是影响癌细胞的超突变过程的副产品。已经有一些证据支持这个方向,并且这个解释被认为是理所当然的。假设沉默突变实际上是中性的,这对影响p53蛋白编码基因的突变过程的研究有重大影响,因为基于这个假设,它们被视为零假设,例如用于测量和比较不同组织中的内源性突变率。由此可见,确定p53基因以及一般所有疾病基因中的沉默突变是否基本上是突变噪声至关重要。在本文中,我们通过测试p53基因内部沉默突变的空间分布与该基因的功能重要特征之间是否存在关系来重新探讨这个话题。为此,我们将沉默突变群体分为三组:那些与其他突变同时出现的(双重突变和多重突变),那些以单突变形式分离出来,但在另一个个体中该相同突变也作为双重突变(或多重突变)的一部分被分离出来的。最后一组由那些总是以单突变形式出现且从未作为双重突变或多重突变一部分的组成。预计最后一组富含功能重要的沉默突变。我们发现所有沉默突变,特别是最后一组的突变,优先位于保守氨基酸位置(即功能重要的氨基酸),并且也倾向于位于疑似剪接增强子内部。值得注意的是,即使消除了突变热点的可能贡献,这种关联仍然存在。此外,我们还提供了额外的证据表明这些假定的剪接增强子是真正的功能增强子。

相似文献

1
Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.编码p53蛋白的基因中的沉默突变优先位于保守氨基酸位置和剪接增强子中。
Mutat Res. 2006 Aug 30;600(1-2):102-12. doi: 10.1016/j.mrfmmm.2006.03.004. Epub 2006 May 2.
2
Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.p53和p16的详细计算研究:利用进化序列分析和疾病相关突变预测等位基因变异的功能后果。
Oncogene. 2003 Feb 27;22(8):1150-63. doi: 10.1038/sj.onc.1206101.
3
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).癌症抑制基因TP53中的错义突变与外显子剪接增强子(ESEs)共定位。
Mutat Res. 2004 Oct 4;554(1-2):175-83. doi: 10.1016/j.mrfmmm.2004.04.014.
4
Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.p53的进化保守性与体细胞突变热点图谱:与p53蛋白结构和功能特征的相关性
Oncogene. 1999 Jan 7;18(1):211-8. doi: 10.1038/sj.onc.1202298.
5
Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.p53基因中的李-弗劳梅尼综合征及李-弗劳梅尼样综合征突变与外显子甲基化和剪接调控元件相关。
Mol Carcinog. 2009 Oct;48(10):895-902. doi: 10.1002/mc.20537.
6
Selective pressures at a codon-level predict deleterious mutations in human disease genes.密码子水平的选择压力可预测人类疾病基因中的有害突变。
J Mol Biol. 2006 May 19;358(5):1390-404. doi: 10.1016/j.jmb.2006.02.067. Epub 2006 Mar 15.
7
Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency.自发多重突变既显示出与时间坐标事件一致的近端间距,也显示出p53缺陷导致的改变。
Mutat Res. 2004 Oct 4;554(1-2):223-40. doi: 10.1016/j.mrfmmm.2004.05.005.
8
Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.甲状腺癌以基因组不稳定为特征:来自p53突变的证据。
Mol Genet Metab. 2001 Feb;72(2):155-63. doi: 10.1006/mgme.2000.3114.
9
Methylation and repeats in silent and nonsense mutations of p53.p53沉默和无义突变中的甲基化与重复序列
Mutat Res. 2006 Jul 25;599(1-2):167-77. doi: 10.1016/j.mrfmmm.2006.03.002. Epub 2006 Apr 19.
10
Tumour p53 mutations exhibit promoter selective dominance over wild type p53.肿瘤p53突变对野生型p53表现出启动子选择性优势。
Oncogene. 2002 Mar 7;21(11):1641-8. doi: 10.1038/sj.onc.1205250.

引用本文的文献

1
Protein folding and tRNA biology.蛋白质折叠与转运RNA生物学
Biophys Rev. 2017 Oct;9(5):573-588. doi: 10.1007/s12551-017-0322-2. Epub 2017 Sep 24.
2
A Massively Parallel Fluorescence Assay to Characterize the Effects of Synonymous Mutations on Expression.一种大规模平行荧光分析方法,用于研究同义突变对表达的影响。
Mol Cancer Res. 2017 Oct;15(10):1301-1307. doi: 10.1158/1541-7786.MCR-17-0245. Epub 2017 Jun 26.
3
Clinical Outcomes of TP53 Mutations in Cancers.癌症中TP53突变的临床结果
Cold Spring Harb Perspect Med. 2016 Sep 1;6(9):a026294. doi: 10.1101/cshperspect.a026294.
4
Whisper mutations: cryptic messages within the genetic code.低语突变:遗传密码中的隐秘信息。
Oncogene. 2016 Jul 21;35(29):3753-9. doi: 10.1038/onc.2015.454. Epub 2015 Dec 14.
5
Alternative splicing for diseases, cancers, drugs, and databases.疾病、癌症、药物及数据库的可变剪接
ScientificWorldJournal. 2013 May 22;2013:703568. doi: 10.1155/2013/703568. Print 2013.
6
Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.在透明质酸合酶 1 (HAS1) 基因迷你基因中内含子的改变将前体 mRNA [校正] 剪接转化为多发性骨髓瘤 (MM) 中的异常模式:MM 患者具有相似的改变。
PLoS One. 2013;8(1):e53469. doi: 10.1371/journal.pone.0053469. Epub 2013 Jan 3.
7
Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.评估良性和恶性涎腺肿瘤中的 TP53 突变。
PLoS One. 2012;7(7):e41261. doi: 10.1371/journal.pone.0041261. Epub 2012 Jul 19.
8
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.p53 突变在经典型和多形性浸润性小叶癌中的研究。
Cell Oncol (Dordr). 2012 Apr;35(2):111-8. doi: 10.1007/s13402-012-0071-y. Epub 2012 Feb 22.
9
Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes.剪接调控位点的同义多态性与神经退行性疾病相关基因中的 CpG 有关。
Neuromolecular Med. 2010 Sep;12(3):260-9. doi: 10.1007/s12017-009-8111-0. Epub 2010 Jan 14.
10
Alternative splicing and tumor progression.可变剪接与肿瘤进展。
Curr Genomics. 2008 Dec;9(8):556-70. doi: 10.2174/138920208786847971.